Format

Send to

Choose Destination
Eur J Oncol Nurs. 2016 Dec;25:77-82. doi: 10.1016/j.ejon.2016.10.002. Epub 2016 Oct 26.

Opioid-taking self-efficacy as influencing emotional status in patients with cancer pain.

Author information

1
Department of Nursing, Koo Founding Sun Yat-Sen Cancer Center, 125 Lide Road, Beitou, Taipei 112, Taiwan. Electronic address: a840512a@gmail.com.
2
College of Nursing, National Taipei University of Nursing and Health Sciences, 365 Ming Te Road, Beitou, Taipei 112, Taiwan. Electronic address: shuyuan@ntunhs.edu.tw.
3
College of Nursing, National Taipei University of Nursing and Health Sciences, 365 Ming Te Road, Beitou, Taipei 112, Taiwan. Electronic address: weiwen@ntunhs.edu.tw.
4
College of Nursing, National Taipei University of Nursing and Health Sciences, 365 Ming Te Road, Beitou, Taipei 112, Taiwan. Electronic address: chiehyu@ntunhs.edu.tw.
5
College of Nursing, National Taipei University of Nursing and Health Sciences, 365 Ming Te Road, Beitou, Taipei 112, Taiwan. Electronic address: sufen@ntunhs.edu.tw.

Abstract

PURPOSE:

The purpose of this study was to evaluate how much of the variance in emotional status amongst Taiwanese cancer patients could be accounted for by opioid-taking self-efficacy.

METHODS:

This cross-sectional study included 109 cancer patients who had taken prescribed opioid analgesics for cancer related pain in the past week and completed the Opioid-Taking Self-Efficacy Scale-CA (OTSES-CA) and Hospital Anxiety and Depression Scale.

RESULTS:

There was a significant and negative correlation between scores on anxiety and self-efficacy total scale (r = -0.29, p < 0.01), self-efficacy communication subscale (r = -0.37, p < 0.01), self-efficacy acquiring help subscale (r = -0.22, p < 0.05) and self-efficacy managing treatment related concerns subscale (r = -0.32, p < 0.01). However, the correlation between scores on depression and the self-efficacy total scale was not significant (r = -0.18, p > 0.05); only the self-efficacy communication subscale was significantly and negatively associated with depression (r = -0.27, p < 0.01). The opioid-taking self-efficacy total scale accounted for 8% of predicting the patients' anxiety. Opioid-taking self-efficacy subscales accounted for 20% (R2 = 0.20, p = 0.000) of the variance in predicting anxiety and 10% (R2 = 0.10, p = 0.02) of the variance in predicting depression.

CONCLUSIONS:

This study highlights the potential importance of a patient's opioid-taking self-efficacy beliefs in their emotional status, which is relevant to cancer pain.

KEYWORDS:

Anxiety; Depression; Emotion; Pain; Self-efficacy

PMID:
27865256
DOI:
10.1016/j.ejon.2016.10.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center